The Patients With CRLM Who Benefit More From Bevacizumab
1 clinical trials · Condition
◉ Watch The Patients With CRLM Who Benefit More From Bevacizumab
| Record | Firm | Date |
|---|---|---|
| Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases (NCT06023173) | Fudan University | 2013-10-01 |
Track The Patients With CRLM Who Benefit More From Bevacizumab automatically
Every clearance here is in the API, with alerts when new ones post.